Placebo (Multiple)

BIOLOGICAL3 trials

Sponsors

Longbio Pharma

Conditions

Chronic Spontaneous UrticariaMyelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)

Phase 1

A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants

CompletedNCT06294301

Longbio PharmaParoxysmal Nocturnal Hemoglobinuria (PNH)

Start: 2023-11-23End: 2024-08-31Updated: 2025-12-15

A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects

CompletedNCT06294275

Longbio PharmaMyelodysplastic Syndrome (MDS)

Start: 2022-09-03End: 2023-08-16Updated: 2025-12-15

A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants

CompletedNCT06294288

Longbio PharmaChronic Spontaneous Urticaria

Start: 2022-07-13End: 2024-03-04Updated: 2025-12-12